vs
Side-by-side financial comparison of AvalonBay Communities (AVB) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $767.9M, roughly 2.0× AvalonBay Communities). AvalonBay Communities runs the higher net margin — 9040.6% vs 4.4%, a 9036.1% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 3.7%). AvalonBay Communities produced more free cash flow last quarter ($1.4B vs $379.8M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 3.8%).
AvalonBay Communities, Inc. is a publicly traded real estate investment trust that invests in apartments.
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
AVB vs ONC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $767.9M | $1.5B |
| Net Profit | $166.0M | $66.5M |
| Gross Margin | — | 90.5% |
| Operating Margin | 64.2% | 12.4% |
| Net Margin | 9040.6% | 4.4% |
| Revenue YoY | 3.7% | 32.8% |
| Net Profit YoY | -41.2% | 143.8% |
| EPS (diluted) | $1.18 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $767.9M | $1.5B | ||
| Q3 25 | $766.8M | $1.4B | ||
| Q2 25 | $760.2M | $1.3B | ||
| Q1 25 | $745.9M | $1.1B | ||
| Q4 24 | $740.5M | $1.1B | ||
| Q3 24 | $734.3M | $1.0B | ||
| Q2 24 | $726.0M | $929.2M | ||
| Q1 24 | $712.9M | $751.7M |
| Q4 25 | $166.0M | $66.5M | ||
| Q3 25 | $381.3M | $124.8M | ||
| Q2 25 | $268.7M | $94.3M | ||
| Q1 25 | $236.6M | $1.3M | ||
| Q4 24 | $282.1M | $-151.9M | ||
| Q3 24 | $372.5M | $-121.3M | ||
| Q2 24 | $253.9M | $-120.4M | ||
| Q1 24 | $173.4M | $-251.2M |
| Q4 25 | — | 90.5% | ||
| Q3 25 | — | 86.1% | ||
| Q2 25 | — | 87.5% | ||
| Q1 25 | — | 85.2% | ||
| Q4 24 | — | 85.8% | ||
| Q3 24 | — | 83.0% | ||
| Q2 24 | — | 85.1% | ||
| Q1 24 | — | 83.4% |
| Q4 25 | 64.2% | 12.4% | ||
| Q3 25 | 65.7% | 11.5% | ||
| Q2 25 | 67.6% | 6.7% | ||
| Q1 25 | 68.5% | 1.0% | ||
| Q4 24 | 63.1% | -7.0% | ||
| Q3 24 | 65.4% | -12.0% | ||
| Q2 24 | 66.6% | -11.5% | ||
| Q1 24 | 67.2% | -34.8% |
| Q4 25 | 9040.6% | 4.4% | ||
| Q3 25 | 49.7% | 8.8% | ||
| Q2 25 | 35.3% | 7.2% | ||
| Q1 25 | 31.7% | 0.1% | ||
| Q4 24 | 38.1% | -13.5% | ||
| Q3 24 | 50.7% | -12.1% | ||
| Q2 24 | 35.0% | -13.0% | ||
| Q1 24 | 24.3% | -33.4% |
| Q4 25 | $1.18 | $0.05 | ||
| Q3 25 | $2.68 | $0.08 | ||
| Q2 25 | $1.88 | $0.06 | ||
| Q1 25 | $1.66 | $0.00 | ||
| Q4 24 | $1.99 | $-0.10 | ||
| Q3 24 | $2.61 | $-0.09 | ||
| Q2 24 | $1.78 | $-0.09 | ||
| Q1 24 | $1.22 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $187.2M | $4.5B |
| Total DebtLower is stronger | $9.3B | $836.4M |
| Stockholders' EquityBook value | $11.6B | $4.4B |
| Total Assets | $22.2B | $8.2B |
| Debt / EquityLower = less leverage | 0.80× | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $187.2M | $4.5B | ||
| Q3 25 | $123.3M | $4.0B | ||
| Q2 25 | $102.8M | $2.8B | ||
| Q1 25 | $53.3M | $2.5B | ||
| Q4 24 | $108.6M | $2.6B | ||
| Q3 24 | $552.4M | $2.7B | ||
| Q2 24 | $545.8M | $2.6B | ||
| Q1 24 | $287.9M | $2.8B |
| Q4 25 | $9.3B | $836.4M | ||
| Q3 25 | $8.7B | — | ||
| Q2 25 | $8.7B | — | ||
| Q1 25 | $8.3B | — | ||
| Q4 24 | $8.1B | — | ||
| Q3 24 | $8.4B | — | ||
| Q2 24 | $8.4B | — | ||
| Q1 24 | $8.0B | — |
| Q4 25 | $11.6B | $4.4B | ||
| Q3 25 | $11.9B | $4.1B | ||
| Q2 25 | $11.9B | $3.8B | ||
| Q1 25 | $11.9B | $3.5B | ||
| Q4 24 | $11.9B | $3.3B | ||
| Q3 24 | $11.9B | $3.4B | ||
| Q2 24 | $11.7B | $3.4B | ||
| Q1 24 | $11.7B | $3.4B |
| Q4 25 | $22.2B | $8.2B | ||
| Q3 25 | $21.9B | $7.6B | ||
| Q2 25 | $21.8B | $6.3B | ||
| Q1 25 | $21.2B | $5.8B | ||
| Q4 24 | $21.0B | $5.9B | ||
| Q3 24 | $21.3B | $5.8B | ||
| Q2 24 | $21.0B | $5.7B | ||
| Q1 24 | $20.6B | $5.7B |
| Q4 25 | 0.80× | 0.19× | ||
| Q3 25 | 0.73× | — | ||
| Q2 25 | 0.72× | — | ||
| Q1 25 | 0.70× | — | ||
| Q4 24 | 0.68× | — | ||
| Q3 24 | 0.70× | — | ||
| Q2 24 | 0.71× | — | ||
| Q1 24 | 0.68× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.7B | $417.3M |
| Free Cash FlowOCF − Capex | $1.4B | $379.8M |
| FCF MarginFCF / Revenue | 183.5% | 25.4% |
| Capex IntensityCapex / Revenue | 34.1% | 2.5% |
| Cash ConversionOCF / Net Profit | 10.07× | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | $2.5B | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7B | $417.3M | ||
| Q3 25 | $477.0M | $402.6M | ||
| Q2 25 | $377.8M | $263.6M | ||
| Q1 25 | $415.9M | $44.1M | ||
| Q4 24 | $1.6B | $75.2M | ||
| Q3 24 | $486.2M | $188.4M | ||
| Q2 24 | $380.0M | $-95.6M | ||
| Q1 24 | $412.9M | $-308.6M |
| Q4 25 | $1.4B | $379.8M | ||
| Q3 25 | $402.2M | $354.5M | ||
| Q2 25 | $317.1M | $219.8M | ||
| Q1 25 | $367.5M | $-12.3M | ||
| Q4 24 | $1.4B | $-17.3M | ||
| Q3 24 | $434.2M | $54.7M | ||
| Q2 24 | $333.0M | $-205.5M | ||
| Q1 24 | $375.4M | $-465.1M |
| Q4 25 | 183.5% | 25.4% | ||
| Q3 25 | 52.5% | 25.1% | ||
| Q2 25 | 41.7% | 16.7% | ||
| Q1 25 | 49.3% | -1.1% | ||
| Q4 24 | 191.0% | -1.5% | ||
| Q3 24 | 59.1% | 5.5% | ||
| Q2 24 | 45.9% | -22.1% | ||
| Q1 24 | 52.7% | -61.9% |
| Q4 25 | 34.1% | 2.5% | ||
| Q3 25 | 9.8% | 3.4% | ||
| Q2 25 | 8.0% | 3.3% | ||
| Q1 25 | 6.5% | 5.0% | ||
| Q4 24 | 26.1% | 8.2% | ||
| Q3 24 | 7.1% | 13.3% | ||
| Q2 24 | 6.5% | 11.8% | ||
| Q1 24 | 5.3% | 20.8% |
| Q4 25 | 10.07× | 6.28× | ||
| Q3 25 | 1.25× | 3.22× | ||
| Q2 25 | 1.41× | 2.79× | ||
| Q1 25 | 1.76× | 34.71× | ||
| Q4 24 | 5.70× | — | ||
| Q3 24 | 1.31× | — | ||
| Q2 24 | 1.50× | — | ||
| Q1 24 | 2.38× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
